Table 5.
Factor | Pre–COVID-19 regulations(January 1, 2018–January 31, 2020) | During COVID-19 pandemic(April 1, 2020–October 27, 2020) | P valueb |
---|---|---|---|
Non-OPC clinic (n=19,232) | |||
n | 14,622 | 4610 | |
Self-reported race, n (%) Other White Black |
1539 (10.5) 11,226 (76.8) 1857 (12.7) |
455 (9.9) 3605 (78.2) 550 (11.9) |
.13 |
Insurance, n (%) Commercial Medicaid Medicare Self-pay and other |
10,235 (70.0) 3992 (27.3) 109 (0.7) 286 (2.0) |
3275 (71.0) 1219 (26.4) 26 (0.6) 90 (2.0) |
.37 |
Prenatal NST, n (%) | 3526 (24.1) | 1157 (25.1) | .18 |
Prenatal biophysical profile, n (%) | 2713 (18.6) | 712 (15.4) | <.001 |
Cesarean delivery, n (%) | 4487 (30.7) | 1394 (30.2) | .56 |
Obstetrician, gynecologist, or midwife attending, n (%) | 14,109 (96.5) | 4472 (97.0) | .092 |
PTB (<37 wk), n (%) | 1580 (10.8) | 458 (9.9) | .094 |
EPTB (<34 wk), n (%) | 528 (3.6) | 143 (3.1) | .10 |
VEPTB (<28 wk), n (%) | 135 (0.9) | 38 (0.8) | .53 |
Indicated PTB, n (%) | 770 (5.3) | 239 (5.2) | .83 |
Spontaneous PTB, n (%) | 810 (5.5) | 219 (4.8) | .038 |
Overall inductions, n (%) | 4974 (34.0) | 1808 (39.2) | <.001 |
Preterm induction indication,c n (%) Preeclampsia Gestational HTN GDM FGR |
187 (24.3) 20 (2.6) 8 (1.0) 14 (1.8) |
50 (20.9) 7 (2.9) 3 (1.3) 2 (0.8) |
.28 .78 .78 .29 |
ADI, mean (SD) | 53.4 (25.8) | 52.8 (25.4) | .17 |
OPC clinic (n=3851) | |||
n | 3065 | 786 | |
Self-reported race, n (%) Other White Black |
260 (8.5) 1021 (33.3) 1784 (58.2) |
81 (10.3) 240 (30.5) 465 (59.2) |
.14 |
Insurance, n (%) Commercial Medicaid Medicare Self-pay and other |
407 (13.3) 2534 (82.7) 69 (2.3) 55 (1.8) |
131 (16.7) 632 (80.4) 12 (1.5) 11 (1.4) |
.054 |
Prenatal NST, n (%) | 10 (0.3) | 1 (0.1) | .35 |
Prenatal biophysical profile, n (%) | 649 (21.2) | 123 (15.6) | <.001 |
Cesarean delivery, n (%) | 923 (30.1) | 221 (28.1) | .27 |
Obstetrician, gynecologist, or midwife attending, n (%) | 2957 (96.5) | 745 (94.8) | .028 |
PTB (<37 wk), n (%) | 383 (12.5) | 87 (11.1) | .28 |
EPTB (<34 wk), n (%) | 111 (3.6) | 26 (3.3) | .67 |
VEPTB (<28 wk), n (%) | 41 (1.3) | 7 (0.9) | .31 |
Indicated PTB, n (%) | 189 (6.2) | 34 (4.3) | .049 |
Spontaneous PTB, n (%) | 194 (6.3) | 53 (6.7) | .67 |
Overall inductions, n (%) | 1105 (36.1) | 290 (36.9) | .66 |
Preterm induction indication,c n (%) Preeclampsia Gestational HTN GDM FGR |
50 (26.5) 1 (0.5) 3 (1.6) 7 (3.7) |
11 (32.4) 0 (0.0) 0 (0.0) 0 (0.0) |
.48 .67 .46 .25 |
ADI, mean (SD) | 78.1 (19.7) | 79.2 (19.6) | .19 |
ADI, area deprivation index; COVID-19, coronavirus disease 2019; EPTB, early preterm birth; FGR, fetal growth restriction; GDM, gestational diabetes mellitus; HTN, hypertension; NST, nonstress test; OPC, outpatient care; PNV, prenatal visit; PTB, preterm birth; SD, standard deviation; VEPTB, very early preterm birth.
February and March were considered a washout period and excluded
Pearson chi-square or 2-sample t test as appropriate
Percentage of preterm inductions.
Lemon. Differential decreases in spontaneous preterm birth during coronavirus disease 2019. Am J Obstet Gynecol MFM 2021.